PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
14552767-1	2003	A series of 5-aryl-3,3-dibutyl-7-(dimethylamino)-1,2-benzothiazepin-4-ol 1,1-dioxides were prepared and were found to inhibit the apical sodium co-dependent bile acid transporter (ASBT) for the potential treatment for hyperlipidemia.	5-aryl-3,3-dibutyl-7-(dimethylamino)-1,2-benzothiazepin-4-ol	12-72	solute carrier family 10 member 2	Homo sapiens	130-178
14552767-1	2003	A series of 5-aryl-3,3-dibutyl-7-(dimethylamino)-1,2-benzothiazepin-4-ol 1,1-dioxides were prepared and were found to inhibit the apical sodium co-dependent bile acid transporter (ASBT) for the potential treatment for hyperlipidemia.	5-aryl-3,3-dibutyl-7-(dimethylamino)-1,2-benzothiazepin-4-ol	12-72	solute carrier family 10 member 2	Homo sapiens	180-184